Home LiteratureArticle Details
PMID: 9643727 Published · ppublish English Case Reports Comment Letter

First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital.

Lancet (London, England) ·Vol. 351 ·No. 9110 ·1998-04-18 ·Pages 1212

Ploy MC, Grélaud C, Martin C, de Lumley L, Denis F

Abstract

暂无摘要

MeSH Terms
Anti-Bacterial Agents/adverse effects,therapeutic use Child, Preschool Female Humans Methicillin Resistance Microbial Sensitivity Tests Opportunistic Infections/drug therapy Sepsis/drug therapy,microbiology Staphylococcal Infections/drug therapy,microbiology Staphylococcus aureus/drug effects Vancomycin/adverse effects,therapeutic use
Chemicals
Anti-Bacterial Agents Vancomycin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Ploy M C
Grélaud C
Martin C
de Lumley L
Denis F
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
DOI
10.1016/s0140-6736(05)79166-2
Published
1998-04-18
Pages
1212
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Corrections
CommentOn
PMID: 9400504
CommentOn
PMID: 9400512
External Links
PubMed source DOI: 10.1016/s0140-6736(05)79166-2 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2